Cargando…
A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
Patients with acquired brain injury (ABI) suffer from cognitive deficits that interfere significantly with their daily lives. These deficits are long-lasting and no treatment options are available. A better understanding of the mechanistic basis for these cognitive deficits is needed to develop nove...
Autores principales: | Schreiber, Rudy, Hollands, Romain, Blokland, Arjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327948/ https://www.ncbi.nlm.nih.gov/pubmed/31660837 http://dx.doi.org/10.2174/1570159X17666191010103044 |
Ejemplares similares
-
Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
por: Cui, Su-Ying, et al.
Publicado: (2019) -
Task- and Treatment Length–Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats
por: Pehrson, Alan L., et al.
Publicado: (2016) -
Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro
por: Greenhill, S.D., et al.
Publicado: (2010) -
Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosterone
por: AlAhmed, S., et al.
Publicado: (2008) -
Limbic system associated membrane protein as a potential target for neuropsychiatric disorders
por: Innos, Jürgen, et al.
Publicado: (2013)